In spite of technological advantages in diagnosis and treatment, lung cancer remains one of
the most deadly malignant neoplasias. Moreover, there are no markers for monitoring response
to treatment. The objective of the study is to associate the number of circulating tumor
cells (CTC) before and after treatment and correlate it with tumor response rate,
progression-free survival and overall survival.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Response rate, progression-free survival and over-all survival
4 years
No
Oscar Arrieta, MD
Principal Investigator
National Counsil of Science and Technology
Mexico: National Council of Science and Technology
INCAN/OfCA204/SO151/CB451/09
NCT01052818
July 2007
Name | Location |
---|